News Releases

Jun 18, 2024
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
Awarding Excellence in Company Culture LOUISVILLE, Colo. --(BUSINESS WIRE)--Jun. 18, 2024-- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, is honored to announce it has been named to Inc. Magazine’s Best Workplaces list . The ranking is a result of a comprehensive,
May 28, 2024
Biodesix to Participate in Two Investor Conferences in June
LOUISVILLE, Colo. --(BUSINESS WIRE)--May 28, 2024-- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton , Chief Executive Officer, will participate in two upcoming investor conferences: William Blair 44 th Annual Growth
May 07, 2024
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
LOUISVILLE, Colo. --(BUSINESS WIRE)--May 7, 2024-- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton , Chief Executive Officer of Biodesix , will present and host in-person 1x1 investor meetings at the 2024 RBCCM
Apr 24, 2024
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
LOUISVILLE, Colo. --(BUSINESS WIRE)--Apr. 24, 2024-- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8 .
Displaying 1 - 10 of 12